Metabolism
Metabolism(代谢)
- PPAR(219)
- 5-alpha Reductase(11)
- 5-Lipoxygenase(11)
- Adenosine Deaminase(10)
- Aminopeptidase(15)
- C14ɑ demethylase(2)
- Carbonic Anhydrase(55)
- CETP(9)
- Cholesterol absorption(1)
- CPT1(2)
- CYP3A/CYP450(22)
- Dehydrogenase(43)
- DHFR(7)
- DGAT(10)
- Dopamine β-hydroxylase(10)
- Enolase(5)
- FAAH(38)
- Factor Xa(61)
- Ferroptosis(198)
- Folate Analogue(2)
- Glucokinase(18)
- HLE(1)
- HMG-CoA Reductase(37)
- HSP(100)
- IDO(46)
- KRAS-PDEδ(3)
- MAO(6)
- Metabolic Enzymes(6)
- Neuronal Metabolism(8)
- Oxidative Phosphorylation(26)
- P450(456)
- PDE(250)
- Phospholipase(130)
- Procollagen C Proteinase(1)
- Saccharometabolism(1)
- SCD(20)
- SGLT(29)
- TPH(4)
- Transferase(26)
- Energy Metabolism
- Inorganic Ions
- ALP(1)
- Carbohydrates(36)
- Uric Acid
- Muscle Metabolism
- MDA
- MPO
- Transaminase(3)
- Glutathione Reductase(1)
- Thioredoxin Reductase
- Catalase(15)
- monooxygenase(1)
- PKM2(1)
- Aldehyde dehydrogenase(1)
- Squalene synthase(1)
- Hydrolase(17)
- ornithine decarboxylase(1)
- Amino acid metabolism(3)
- phosphatases(103)
- Pyruvate kinase(13)
- Others(64)
- MGL(1)
- Galactosidase(2)
- 12-Lipoxygenase(1)
- Fatty Acid Synthase (FASN)(9)
- Dihydroorotate Dehydrogenase(13)
- Bile Acids & Microbiome(131)
- Bone Growth & Remodeling(55)
- Carbohydrate Metabolism(166)
- Cofactors & Vitamins(87)
- Dyslipidemias(109)
- Inborn Errors of Metabolism(100)
- Metabolic Syndrome(22)
- Necroptosis(12)
- Necrosis(19)
- Nutrient Sensing(14)
- Phosphodiesterase(34)
- Reproductive Biology(184)
- Thermogenesis(10)
- Sterol Biosynthesis(42)
- Prolyl Hydroxylation Enzymes(2)
- Biliary System(16)
- Metabolic Disease(5)
- Fat Mass and Obesity-associated Protein (FTO)(5)
- SHIP(1)
- FOXO
- Furin(1)
- Liposome(8)
- MetAP
- PGC-1α
- PI5P4K(1)
- Metabolic Diseases(2)
Metabolism 相关产品(3072)
- GC14584Fenofibric acidCAS: 42017-89-0纯度: >99.50%
An agonist of PPARα, PPARγ, and PPARδ and an active metabolite of fenofibrate
- GC147811-Aminobenzotriazole (ABT)CAS: 1614-12-6纯度: >99.50%
1-Aminobenzotriazole (ABT)是具有口服活性的细胞色素P450(CYP)的非特异性和不可逆抑制剂。
- GC15056β-NicotyrineCAS: 487-19-4纯度: >98.00%
β-Nicotyrine是一种尼古丁的热解产物,可与细胞色素P450 (CYP) isoforms CYP2A6和CYP2A13结合,并能更有效地抑制CYP2A6的活性
- GC15130Alogliptin (SYR-322)CAS: 850649-61-5纯度: >98.00% / >99.00%
Alogliptin (SYR-322) (SYR-322 free base) 是一种有效的、选择性的、具有口服活性的 DPP-4 抑制剂,IC50 <10 nM,选择性比 DPP-8 和 DPP-9 高 10,000 倍以上.
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC14571 | SIRT2-IN-8 | 115687-05-3 | - | |
SIRT2-IN-8 是一种有效的 SIRT2 抑制剂。 | ||||
| GC14584 | Fenofibric acid | 42017-89-0 | >99.50% | |
An agonist of PPARα, PPARγ, and PPARδ and an active metabolite of fenofibrate | ||||
| GC14591 | Hemin chloride | 16009-13-5 | >98.00% | |
氯化血红素是血红素加氧酶(HO)-1的底物,可诱导多种细胞表达HO-1,发挥抗氧化和抗炎作用。 | ||||
| GC14595 | MCC-555 | 161600-01-7 | - | |
A structural homolog of rosiglitazone | ||||
| GC14601 | BW 755C | 66000-40-6 | - | |
Dual 5-LO/COX inhibitor | ||||
| GC14618 | PPOH | 206052-01-9 | - | |
Selective inhibitor of epoxygenation reactions catalyzed by CYP4A2 and CYP4A3 | ||||
| GC14697 | HA 130 | 1229652-21-4 | >99.00% | |
A reversible autotaxin inhibitor | ||||
| GC14713 | 3-Deazaadenosine | 6736-58-9 | - | |
3-Deazaadenosine(盐酸盐)是 S-腺苷高半胱氨酸水解酶的抑制剂,Ki 为 3.9 µM。 | ||||
| GC14727 | CCCP | 555-60-2 | >98.00% / >99.50% | |
Carbonylcyanide-3-chlorophenylhydrazone (CCCP) 是一种质子载体,可导致线粒体内膜中的质子梯度解偶联,从而抑制 ATP 合成速率。 | ||||
| GC14757 | AGI-6780 | 1432660-47-3 | >98.00% | |
A potent, selective inhibitor of mutant IDH2 | ||||
| GC14781 | 1-Aminobenzotriazole (ABT) | 1614-12-6 | >99.50% | |
1-Aminobenzotriazole (ABT)是具有口服活性的细胞色素P450(CYP)的非特异性和不可逆抑制剂。 | ||||
| GC14787 | Curcumin | 458-37-7 | >98.00% | |
A yellow pigment with diverse biological activities | ||||
| GC14827 | Linagliptin (BI-1356) | 668270-12-0 | >99.50% | |
A potent DPP-4 inhibitor | ||||
| GC14851 | Vidofludimus | 717824-30-1 | >98.50% | |
An immunosuppressive drug that inhibits DHODH | ||||
| GC14875 | NSC 663284 | 383907-43-5 | >99.50% | |
Inhibitor of Cdc25 isoforms | ||||
| GC14915 | Gemfibrozil | 25812-30-0 | >99.50% | |
A PPARα and PPARγ agonist | ||||
| GC14921 | CPI-613 (Devimistat) | 95809-78-2 | >98.00% | |
An inhibitor of α-ketoglutarate dehydrogenase | ||||
| GC14948 | Pioglitazone | 111025-46-8 | >99.50% | |
Pioglitazone属于格列酮类或噻唑烷二酮类,是一系列口服降糖药。 | ||||
| GC14954 | L-Canaline | 496-93-5 | >95.00% | |
A natural inhibitor of aminotransferases | ||||
| GC15037 | Sildenafil mesylate | 1308285-21-3 | - | |
A PDE5 inhibitor | ||||
| GC15056 | β-Nicotyrine | 487-19-4 | >98.00% | |
β-Nicotyrine是一种尼古丁的热解产物,可与细胞色素P450 (CYP) isoforms CYP2A6和CYP2A13结合,并能更有效地抑制CYP2A6的活性 | ||||
| GC15085 | G3335 | 36099-95-3 | - | |
A PPARγ antagonist III | ||||
| GC15088 | LX-4211 | 1018899-04-1 | >98.50% | |
LX-4211是一种口服的强效双重SGLT2/1抑制剂,对SGLT1和SGLT2的IC 50 值分别为36nM和1.8nM。 | ||||
| GC15130 | Alogliptin (SYR-322) | 850649-61-5 | >98.00% / >99.00% | |
Alogliptin (SYR-322) (SYR-322 free base) 是一种有效的、选择性的、具有口服活性的 DPP-4 抑制剂,IC50 <10 nM,选择性比 DPP-8 和 DPP-9 高 10,000 倍以上. | ||||
